Home › Funds › Beartown Capital Management, LLC › ABVX
Beartown Capital Management, LLC position in ABVX
ABIVAX SA · Health Care
Beartown Capital Management, LLC reported holding 22,500 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 1.48% of its reported portfolio and ranking #19 among its reported holdings. Beartown Capital Management, LLC has disclosed ABVX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Beartown Capital Management, LLC's ABVX position evolved
Beartown Capital Management, LLC first disclosed a stake in ABVX in Q2 2026 at 20,000 shares (US$2.7M). Across 2 filings, Beartown Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 22,500 shares valued at US$2.2M — an increase of 2,500 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 20.00K | $2.67M | New |
| Q3 2026 | 22.50K | $2.23M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABVX and 13F data
ABVX (ABIVAX SA) is a Health Care company. 71 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABVX
- TCG Crossover Management, LLC 6.01M sh · $800.60M · Q2 2026
- Helikon Investments Ltd 4.22M sh · $418.15M · Q3 2026
- Darwin Global Management, Ltd. 3.62M sh · $348.22M · Q2 2026
- Vestal Point Capital, LP 2.35M sh · $313.09M · Q2 2026
- Caligan Partners LP 1.56M sh · $207.61M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.65M sh · $163.56M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 1.13M sh · $150.92M · Q2 2026
- Logos Global Management LP 1.02M sh · $136.46M · Q2 2026
- Octagon Capital Advisors LP 993.00K sh · $132.33M · Q2 2026
- Eversept Partners, LP 913.88K sh · $121.78M · Q2 2026
- Cormorant Asset Management, LP 675.00K sh · $89.95M · Q2 2026
- Boxer Capital Management, LLC 605.00K sh · $80.62M · Q2 2026
More on Beartown Capital Management, LLC
FAQ
How long has Beartown Capital Management, LLC held ABVX?
Beartown Capital Management, LLC has disclosed ABVX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Beartown Capital Management, LLC's current position in ABVX?
As of Q3 2026, Beartown Capital Management, LLC holds 22.50K shares of ABVX (ABIVAX SA), valued at $2.23M, representing 1.48% of its reported portfolio and ranking #19.
Has Beartown Capital Management, LLC been buying or selling ABVX?
In the latest 13F filing (Q3 2026), Beartown Capital Management, LLC increased its position in ABVX.
Which other funds hold ABVX?
Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.